Alessandra Bartolozzi

Title: Alessandra Bartolozzi: Innovator in AHR Antagonists

Introduction

Alessandra Bartolozzi is a prominent inventor based in Gladwyne, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the aryl hydrocarbon receptor (AHR). Her work is crucial in addressing various diseases, including cancer.

Latest Patents

Alessandra holds a patent for "Fused imidazole derivatives as AHR antagonists." This patent encompasses compounds of formulae (I)-(VI) and their pharmaceutically acceptable salts. The disclosure includes pharmaceutical compositions, methods of preparation, and intermediate compounds useful for treating or preventing diseases associated with dysregulated immune responses and aberrant AHR signaling.

Career Highlights

Alessandra is currently associated with Sail Biomedicines, where she continues to innovate in the pharmaceutical sector. Her expertise in AHR antagonists positions her as a key player in the development of new therapeutic strategies.

Collaborations

She collaborates with notable colleagues, including John Robert Proudfoot and Timothy Briggs, who contribute to her research and development efforts.

Conclusion

Alessandra Bartolozzi's work in the field of AHR antagonists exemplifies her commitment to advancing medical science. Her innovative approach and collaboration with esteemed colleagues highlight her significant role in the pharmaceutical industry.